On ECHEMI
Home > Drugs > Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd.
Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd.
  • Founded in:

    1986-12-19
  • Country:

    China China
  • Address:

    No. 56, Tianhe Road, Economic and Technological Development Zone, Linping District, Hangzhou City, Zhejiang Province
  • Tax NO.:

    91330000143833309Q
  • Registered Funds:

    1,066.8 million yuan
  • Website:

  • Email:

Related Drugs
ACYW135 group meningococcal polysaccharide vaccine
Name Description Content CAS NO. Registered Holders
ACYW135 group meningococcal polysaccharide

Induce an immune response against meningococci

More

Induce an immune response against meningococci

0
Influenza virus split vaccine
The composition of this vaccine is in line with the strains recommended by WHO for the current year. Each dose of vaccine contains three strains of antigens: type A1, type A3, and type B. Type A1 (New Caledonia/20/99 (H1N1) reassortant [IVR-116 strain]) Hemagglutinin content: ge; 12mu; g Type A3 (Fujian/41I/02 (H3N2) similar strain [NYMCX-147 strain]) Hemagglutinin content: ge; 12mu; g Type B (B/Shanghai/36I/02 similar strain [B/Jiangsu/10/2003 strain]) Hemagglutinin content: ge; 12mu; g
Name Description Content CAS NO. Registered Holders
Type A1 (New Caledonia/20/99 (H1N1) reassortant [IVR-116 strain])

Inducing immunity to prevent influenza virus infection

More

Inducing immunity to prevent influenza virus infection

ge;12mu;g 0
Type A3 (Fujian/41I/02(H3N2) similar strain [NYMCX-147 strain])

Inducing immunity to prevent influenza virus infection

More

Inducing immunity to prevent influenza virus infection

ge;12mu;g 0
Type B (similar strains of B/Shanghai/36I/02 [B/Jiangsu/10/2003])

Inducing immunity to prevent influenza virus infection

More

Inducing immunity to prevent influenza virus infection

ge;12mu;g 0
Group A and C meningococcal polysaccharide vaccines
Name Description Content CAS NO. Registered Holders
Group A and C meningococcal polysaccharides

No specific description provided

More

No specific description provided

0
Bivalent inactivated vaccine for hemorrhagic fever with renal syndrome (gerbil kidney cells)
Name Description Content CAS NO. Registered Holders
Bivalent inactivated vaccine for hemorrhagic fever with renal syndrome

It is not possible to clearly extract a specific description of the pharmacological action from the above information

More

It is not possible to clearly extract a specific description of the pharmacological action from the above information

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.